indica News Bureau-
Silicon Valley-based HD Medical, a developer of digital health tools for AI-enabled detection and management of cardiovascular disease, announced the expansion of its senior management team doctor, Rosemary Ku as its Chief Medical Officer.
The appointment was announced through a press note on Tuesday, April 23 by Arvind Thiagarajan, Founder and CEO of HD Medical, Inc. He stated, “HD Medical’s ability to gather comprehensive cardiovascular data remotely is a game changer in modern healthcare.”
Thiagarajan, known for developing the world’s first Intelligent Stethoscope with Integrated ECG called “HD Steth,” which can provide Instant Cardiac Insight, commented on Ku joining the team, “The potential to intervene before catastrophic events can save lives and maximize the quality of life for those at risk. Dr. Ku will not only help clinically validate HD Medical’s existing technology but will also leverage cutting edge science to develop proprietary tools for the advancement of cardiac care.”
Dr. Rosemary, with dual-board certification in Internal Medicine and Preventive Medicine, is a practicing physician at Kaiser Permanente and comes to HD Medical from Lark Health where she served as the Chief Medical Officer focusing on chronic disease management. She previously served as Chief Medical and Strategy Officer for Restore Health and helped build the company from concept through acquisition through Zillion Group, Inc. in 2017.
She majored in Molecular Biology with a Certificate in Neuroscience at Princeton University and went on to obtain her MD/MBA from Columbia University as well as a Master’s in Public Health in Health Policy and Management from UC Berkeley.
In her new role at HD Medical, Dr. Ku will guide HD Medical’s product vision and roadmap interface with the FDA, oversee numerous clinical trials, as well as contribute to marketing and investor relations.
“For-profit companies have typically focused on building new technologies for consumers with both access and willingness to pay. HD Medical is different. HD Medical strives to develop the world’s best cardiac screening and monitoring tools for communities that need it the most,” Dr. Ku, Chief Medical Officer at HD Medical, Inc. said through a press note.
“With this mission, the company is rapidly opening new markets at the intersection of social impact and growth in India and rest of Asia through mass screening of children for congenital heart disease. HD Medical is pioneering a model for how companies in Silicon Valley can accelerate the dissemination of life-changing technology to underserved communities while still meeting investor expectations. I’m honored to help drive HD Medical’s clinical validation strategy, social impact, and growth.” adds Dr. Ku.